jessica

14 POSTS 0 COMMENTS

Omar Ishrak to step down as Medtronic CEO next year

Omar Ishrak, Medtronic’s chairman and CEO is to retire on 26 April 2020, following the end of the company’s current fiscal year. Also, the...

Omar Ishrak to step down as Medtronic CEO next year

Omar Ishrak, Medtronic’s chairman and CEO is to retire on 26 April 2020, following the end of the company’s current fiscal year. Also, the...

ZOLL Medical completes acquisition of Cardiac Science

ZOLL Medical has confirmed that it has completed the previously announced acquisition of Cardiac Science Corporation, a leading provider of automated external defibrillators (AEDs), related services,...

Research demonstrates the promise of algorithm-based ambulatory cardiac monitoring

iRhythm Technologies has announced the publication of a new study in Nature Medicine showing expert-level detection of cardiac arrhythmias using a new deep learning,...

AI-based solution to screen atrial fibrillation to improve stroke prevention

Maisense, a start-up company specialising in stroke prevention, has recently introduced an AI-based solution that can screen stroke through early detection of atrial fibrillation...

DIAMOND-AF paroxysmal study complete with first enrolment in DIAMOND-AF II persistent...

EPIX Therapeutics, a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AF), has announced...

New data on the VASCADE MVP system for multi-vessel closure following...

Cardiva Medical, an innovator in the field of vascular closure, has announced that new data from the randomised AMBULATE study will be presented in...

CathVision receives new quality standard certification

CathVision, an early stage medical device company developing an advanced cardiac electrophysiology recording system, CUBE, has announced that the company received ISO 13485:2016 certification...

Adagio Medical treats first atrial fibrillation patients using new One Shot+...

Adagio Medical, the developer of the iCLAS technology—the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias—announces that the...

Biosense Webster announces first patients enrolled in post-market approval study for...

Johnson & Johnson have announced that Biosense Webster has received approval from the US Food and Drug Administration (FDA) for its VISITAG SURPOINT External...

LivaNova launches international pivotal study evaluating use of autonomic regulation therapy...

LivaNova has announced the first successful implantation of the Vitaria system in a patient enrolled in the Autonomic regulation therapy to enhance myocardial function...

AtaCor Medical raises US$8.8M to develop substernal cardiac pacing system

AtaCor Medical has announced that it has completed a US$8.8M Series A financing. Co-led by Boston-based Broadview Ventures and Israel-based aMoon Ventures, the financing...

First patient randomised in the phase 3 NODE-301 trial evaluating etripamil

Milestone Pharmaceuticals, a clinical-stage cardiovascular company, announced that the first patient has been randomised in its phase 3 clinical study of etripamil. Etripamil is...

Medtronic begins pilot study of investigational extravascular ICD system

Medtronic plc have announced the start of a pilot study of its investigational extravascular implantable cardioverter defibrillator (EV ICD) system, in which a lead...